Abstract
Colorectal cancer (CRC) remains an important public health problem in the world. Long noncoding RNA (lncRNA) is an RNA molecular that is longer than 200 nucleotides and cannot be translated into a protein. Recent studies have shown that lncRNAs play important roles in carcinogenesis and cancer metastasis. The aim of this study was to evaluate the expression and biological role of lncRNA maternally expressed gene 3 (MEG3) in colorectal cancer. Quantitative real-time-PCR (qRT-PCR) was performed to investigate the expression of MEG3 in tumor tissues and corresponding nontumor colorectal tissues from 62 patients. The lower expression of MEG3 was remarkably correlated with low histological grade, deep tumor invasion, and advanced tumor node metastasis (TNM) stage. Multivariate analyses revealed that MEG3 expression served as an independent predictor for overall survival. Further experiments revealed that overexpressed MEG3 significantly inhibited CRC cell proliferation both in vitro and in vivo. In conclusion, our study demonstrated that MEG3 is involved in the development and progression of colorectal cancer by regulating cell proliferation and shows that MEG3 may be a potential diagnostic and prognostic target in patients with colorectal cancer.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.
Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–61.
Mattick JS, Taft RJ, Faulkner GJ. A global view of genomic information—moving beyond the gene and the master regulator. Trends Genet. 2010;26:21–8.
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–986.
Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71:3–7.
Benetatos L, Vartholomatos G, Hatzimichael E. Meg3 imprinted gene contribution in tumorigenesis. Int J Cancer. 2011;129:773–9.
Zhou Y, Zhang X, Klibanski A. Meg3 noncoding Rna: a tumor suppressor. J Mol Endocrinol. 2012;48:R45–53.
Schuster-Gossler K, Bilinski P, Sado T, Ferguson-Smith A, Gossler A. The mouse gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn. 1998;212:214–28.
da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian dlk1-dio3 domain. Trends Genet. 2008;24:306–16.
Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA meg3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–74.
Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, et al. Loss of imprinting and allelic switching at the dlk1-meg3 locus in human hepatocellular carcinoma. PLoS One. 2012;7:e49462.
Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, et al. Downregulated meg3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 2013;9:407–11.
Balik V, Srovnal J, Sulla I, Kalita O, Foltanova T, Vaverka M, et al. Meg3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. J Neurooncol. 2013;112:1–8.
Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived meg3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88:5119–26.
Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, et al. Maternally expressed gene 3 (meg3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology. 2010;151:939–47.
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by meg3 non-coding RNA. J Biol Chem. 2007;282:24731–42.
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA hotair reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.
Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding RNA anril is required for the prc2 recruitment to and silencing of p15(ink4b) tumor suppressor gene. Oncogene. 2011;30:1956–62.
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, et al. Tgf-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20:1531–41.
Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, et al. Pcat-1, a long noncoding RNA, regulates brca2 and controls homologous recombination in cancer. Cancer Res. 2014;74:1651–60.
Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA hotair is associated with hepatocellular carcinoma progression. J Int Med Res. 2011;39:2119–28.
Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, et al. Upregulation of mir-196a and hotair drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012;72:1126–36.
Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding RNA hotair regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71:6320–6.
Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, et al. Long noncoding RNA anril indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of mir-99a/mir-449a. Oncotarget. 2014;5:2276–92.
Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA gas5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31:253.
Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, et al. The melanoma-upregulated long noncoding RNA spry4-it1 modulates apoptosis and invasion. Cancer Res. 2011;71:3852–62.
Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012;3:32.
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, Sui H, Tang Y, Wang Y, Liu N, Ren J, Hou F, Li Q. Long non-coding rna malat1 promotes tumour growth and metastasis in colorectal cancer through binding to sfpq and releasing oncogene ptbp2 from sfpq/ptbp2 complex. Br J Cancer. 2014.
Han Y, Yang YN, Yuan HH, Zhang TT, Sui H, Wei XL, et al. Uca1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 2014;46:396–401.
Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang D, et al. Braf-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition. Oncol Lett. 2014;8:869–75.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dan-dan Yin and Zhi-jun Liu contributed equally to this work and should be regarded as joint first authors.
Rights and permissions
About this article
Cite this article
Yin, Dd., Liu, Zj., Zhang, E. et al. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumor Biol. 36, 4851–4859 (2015). https://doi.org/10.1007/s13277-015-3139-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-015-3139-2